NervGen Pharma Corp. (NGEN) stock
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.90−0.06 (-3.06%)
Close on Nov 18, 2026Market cap $151.33MP/E –Yield –
NervGen Pharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for NervGen Pharma
NervGen Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?